Northern Trust’s Sinovac Biotech, Ltd SVA Stock Holding History

Northern Trust’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,787	Closed	–	–	4642
2023 Q3	$0	Hold	13,787	–	–	﹤0.01%	4619
2023 Q2	$0	Buy	+13,787	New	–	﹤0.01%	4682
2022 Q4	–	Sell	-13,787	Closed	-$55K	–	4798
2022 Q3	$55K	Hold	13,787	–	–	﹤0.01%	4303
2022 Q2	$55K	Buy	+13,787	New	+$55K	﹤0.01%	4380
2022 Q1	–	Sell	-13,787	Closed	-$55K	–	4886
2021 Q4	$55K	Hold	13,787	–	–	﹤0.01%	4581
2021 Q3	$55K	Hold	13,787	–	–	﹤0.01%	4524
2021 Q2	$55K	Hold	13,787	–	–	﹤0.01%	4481
2021 Q1	$55K	Sell	13,787 -8,587	-38%	-$34.3K	﹤0.01%	4375
2020 Q4	$55K	Hold	22,374	–	–	﹤0.01%	4226
2020 Q3	$55K	Hold	22,374	–	–	﹤0.01%	4097
2020 Q2	$55K	Hold	22,374	–	–	﹤0.01%	4046
2020 Q1	$55K	Hold	22,374	–	–	﹤0.01%	3939
2019 Q4	$55K	Hold	22,374	–	–	﹤0.01%	4046
2019 Q3	$55K	Hold	22,374	–	–	﹤0.01%	4041
2019 Q2	$55K	Hold	22,374	–	–	﹤0.01%	4070
2019 Q1	$144K	Hold	22,374	–	–	﹤0.01%	3839
2018 Q4	$155K	Hold	22,374	–	–	﹤0.01%	3844
2018 Q3	$170K	Buy	+22,374	New	+$161K	﹤0.01%	3902

Other funds holding SVA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Northern Trust's SVA Position: Q4 2023 in Review

Northern Trust sold out of Sinovac Biotech, Ltd (SVA) in Q4 2023, closing a stake of 13,787 shares.

Northern Trust first reported a position in SVA in Q3 2018 and held it in 18 quarters. The position peaked at $170K in Q3 2018. 8 funds tracked by Wall St. Rank hold SVA as of Q4 2023.

Northern Trust reported no remaining Sinovac Biotech, Ltd position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 13,787 Sinovac Biotech, Ltd shares in Q4 2023.
Northern Trust first reported a position in Sinovac Biotech, Ltd in Q3 2018 and held it in 18 quarters.
Northern Trust's Sinovac Biotech, Ltd position peaked at $170K in Q3 2018.
8 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.